Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

Researchers are experimenting with memory-based activities as a way to treat Alzheimer's, saying it can boost cognitive ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

A doctor says a common ear problem associated with getting older is linked to dementia and can be treated. Dr Anelyssa ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

or mild dementia due to AD, offers two dosing schedules. After an initial phase of once every two weeks for 18 months, patients can transition to the four-week dosing regimen. The FDA’s decision is ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

A new blood test is being trialed in the UK to detect the early signs of dementia. It is hoped it could identify patients ...